.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
US Army
AstraZeneca
Covington
Teva
Merck
Mallinckrodt
Julphar
Boehringer Ingelheim
Citi

Generated: December 14, 2017

DrugPatentWatch Database Preview

Fospropofol disodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for fospropofol disodium and what is the scope of fospropofol disodium freedom to operate?

Fospropofol disodium
is the generic ingredient in one branded drug marketed by Eisai Inc and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Fospropofol disodium has thirty-four patent family members in twenty-five countries.

Summary for fospropofol disodium

US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Clinical Trials: 166
Drug Prices:see low prices
DailyMed Link:fospropofol disodium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Eisai IncLUSEDRAfospropofol disodiumSOLUTION;INTRAVENOUS022244-001Dec 12, 2008DISCNNoNo► Subscribe► Subscribe► SubscribeYY► Subscribe
Eisai IncLUSEDRAfospropofol disodiumSOLUTION;INTRAVENOUS022244-001Dec 12, 2008DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: fospropofol disodium

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,451,776 Water soluble prodrugs of hindered alcohols► Subscribe
7,244,718Water soluble prodrugs of hindered alcohols► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: fospropofol disodium

Country Document Number Estimated Expiration
Germany69930269► Subscribe
European Patent Office1683803► Subscribe
Spain2268876► Subscribe
Russian Federation2235727► Subscribe
Portugal1102776► Subscribe
Hungary0200317► Subscribe
Slovenia1102776► Subscribe
Australia769755► Subscribe
Brazil9912853► Subscribe
New Zealand509795► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Citi
Healthtrust
Fuji
Chubb
McKinsey
Argus Health
AstraZeneca
QuintilesIMS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot